Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, Benatar M, Filippi M, Goldstein LH, van den Heuvel M, Kalra S, Lulé D, Mohammadi B; first Neuroimaging Symosium in ALS (NISALS). Turner MR, et al. Among authors: grosskreutz j. Lancet Neurol. 2011 May;10(5):400-3. doi: 10.1016/S1474-4422(11)70049-7. Lancet Neurol. 2011. PMID: 21511189 No abstract available.
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
Filippi M, Agosta F, Abrahams S, Fazekas F, Grosskreutz J, Kalra S, Kassubek J, Silani V, Turner MR, Masdeu JC; European Federation of Neurological Societies. Filippi M, et al. Among authors: grosskreutz j. Eur J Neurol. 2010 Apr;17(4):526-e20. doi: 10.1111/j.1468-1331.2010.02951.x. Epub 2010 Feb 2. Eur J Neurol. 2010. PMID: 20136647 Free PMC article.
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
Cudkowicz ME, van den Berg LH, Shefner JM, Mitsumoto H, Mora JS, Ludolph A, Hardiman O, Bozik ME, Ingersoll EW, Archibald D, Meyers AL, Dong Y, Farwell WR, Kerr DA; EMPOWER investigators. Cudkowicz ME, et al. Lancet Neurol. 2013 Nov;12(11):1059-67. doi: 10.1016/S1474-4422(13)70221-7. Epub 2013 Sep 23. Lancet Neurol. 2013. PMID: 24067398 Clinical Trial.
Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
Filippi M, Agosta F, Grosskreutz J, Benatar M, Kassubek J, Verstraete E, Turner MR; Neuroimaging Society in ALS (NiSALS). Filippi M, et al. Among authors: grosskreutz j. Lancet Neurol. 2015 Aug;14(8):786-788. doi: 10.1016/S1474-4422(15)00134-9. Lancet Neurol. 2015. PMID: 26194923 No abstract available.
Mind the gap: the mismatch between clinical and imaging metrics in ALS.
Verstraete E, Turner MR, Grosskreutz J, Filippi M, Benatar M; attendees of the 4th NiSALS meeting. Verstraete E, et al. Among authors: grosskreutz j. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):524-9. doi: 10.3109/21678421.2015.1051989. Epub 2015 Sep 24. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26402254
A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis.
Müller HP, Turner MR, Grosskreutz J, Abrahams S, Bede P, Govind V, Prudlo J, Ludolph AC, Filippi M, Kassubek J; Neuroimaging Society in ALS (NiSALS) DTI Study Group. Müller HP, et al. Among authors: grosskreutz j. J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):570-9. doi: 10.1136/jnnp-2015-311952. Epub 2016 Jan 8. J Neurol Neurosurg Psychiatry. 2016. PMID: 26746186
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterlé S, Dengler R, Meyer T, Zierz S, Kassubek J, Fischer W, Dreyhaupt J, Grehl T, Hermann A, Grosskreutz J, Witting A, Van Den Bosch L, Spreux-Varoquaux O; GERP ALS Study Group; Ludolph AC, Dupuis L. Vercruysse P, et al. Among authors: grosskreutz j. Brain. 2016 Apr;139(Pt 4):1106-22. doi: 10.1093/brain/aww004. Epub 2016 Mar 16. Brain. 2016. PMID: 26984187 Clinical Trial.
179 results